Predictors of noncompliance to pulmonary tuberculosis treatment: An insight from South America

PLoS One. 2018 Sep 11;13(9):e0202593. doi: 10.1371/journal.pone.0202593. eCollection 2018.

Abstract

Purpose: To investigate the factors associated with a higher risk of noncompliance to tuberculosis (TB) treatment in Porto Alegre, Brazil.

Methods: We identified 478 adult patients for this case-control study undergoing treatment for confirmed pulmonary TB. Cases (noncompliance) were defined as patients who stopped treatment for more than 30 consecutive days (n = 118). Controls were defined as all patients who completed treatment and were cured (n = 360). Factors associated with noncompliance were calculated with unadjusted and adjusted odds ratio (OR).

Results: The rate of noncompliance in our study was 25%. The factors of noncompliance after adjustments in the overall population were, in order of magnitude, living in an area of lower income (OR = 4.35, 95%CI: 2.50-7.58), abuse of drugs (OR = 2.73, 95%CI: 1.47-5.09), nonadherence to a previous treatment regimen (OR = 2.1, 95%CI: 1.28-3.45), and history of smoking (OR = 1.72, 95%CI: 1.00-3.00). Age, race, gender, level of education, HIV infection or diabetes status were not associated with a higher risk of noncompliance. In the subgroup of re-treatment cases, poverty (OR = 2.65; 95%CI = 1.06-6.66), smoking history (OR = 2.94; 95%CI = 1.09-7.92), male gender (OR = 3.25; 95%CI = 1.32-8.0), and younger age (OR = 4.3; 95%CI = 1.15-16.07) were also associated with a higher risk of dropout.

Conclusion: Predictors of poor compliance to TB treatment were low income, abuse of drugs, re-treatment cases and history of smoking.

MeSH terms

  • Adult
  • Brazil / epidemiology
  • Case-Control Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Patient Compliance* / statistics & numerical data
  • Poverty / statistics & numerical data
  • Risk Factors
  • Smoking / epidemiology
  • Socioeconomic Factors
  • Surveys and Questionnaires
  • Tuberculosis, Pulmonary / drug therapy*

Grants and funding

The authors received no specific funding for this work.